Metobolic adaptation of sulfide and its application in Urechis unicinctus

Zhifeng Zhang,Sifeng Wang,Kyoung Ho Kang,Yubin Ma,Mingyu Shao,Zhuojun Ma

DOI: https://doi.org/10.1016/j.jbiotec.2008.07.1257

IF: 3.595

2008-01-01

Journal of Biotechnology

Abstract:Atherosclerosis is a chronic inflammatory disease that causes most heart attacks and strokes, making it the biggest killer in the world. Although cholesterol-lowering drugs have dramatically reduced these major adverse cardiovascular events, there remains a high residual risk called inflammatory risk. Atherosclerosis has an autoimmune component that can be manipulated by immunologic approaches including vaccination. Vaccination is attractive, because it is antigen-specific, does not impair host defense, and provides long-term protection. Several candidate antigens for atherosclerosis vaccine development have been identified and have been shown to reduce atherosclerosis in animal models. In this review, we focus on two different types of atherosclerosis vaccines: antibody-inducing and regulatory T cell-inducing.